发明名称 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
摘要 Treatment of CNS disorders with (1R,4S)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine; and (1S,4R)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine is disclosed. A process for preparing 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine is also disclosed. The process includes the preparation of all four isomers of N-[4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl]formamide, which are also useful.
申请公布号 US9072699(B2) 申请公布日期 2015.07.07
申请号 US201414152377 申请日期 2014.01.10
申请人 Sunovion Pharmaceuticals Inc. 发明人 Jerussi Thomas;Fang Qun Kevin;Currie Mark G.
分类号 A61K31/135;C07C211/42 主分类号 A61K31/135
代理机构 Heslin, Rothenberg, Farley & Mesiti, P.C. 代理人 Heslin, Rothenberg, Farley & Mesiti, P.C.
主权项 1. A method for treating cerebral function disorder, wherein said cerebral function disorder is lowering of attention, the method comprising administering to a patient in need of treatment for said cerebral function disorder a therapeutically effective amount of a compound of formula PQ:or a salt thereof.
地址 Marlborough MA US